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RESEARCH ARTICLE
Evaluation of Two Internalizing
Carcinoembryonic Antigen Reporter Genes
for Molecular Imaging
Bhaswati Barat, Vania E. Kenanova, Tove Olafsen, Anna M. Wu
Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA,
Box 951770, 570 Westwood Plaza, Los Angeles, CA 90095-1770, USA
Abstract
Purpose: The objective of this article is to develop internalizing positron emission tomography
(PET) reporter genes for tracking genetically modified T cells in vivo.
Procedures: The transmembrane and cytoplasmic domains of the human transferrin receptor
(TfR) and CD5 were each fused to the carcinoembryonic (CEA) minigene N-A3 and expressed
in Jurkat T cells. Internalization was evaluated by confocal microscopy or by intracellular uptake
of 125I-labeled anti-CEA scFv-Fc. Reporter gene-transfected Jurkat xenografts in mice were
analyzed by immunohistochemistry (IHC) and imaged by PET using 124I- or 64Cu-scFv-Fc as
tracers.
Results: Surface expression of TR(1–99)-NA3 was lower than that of NA3-CD5. Both reporter
genes were internalized following binding of the anti-CEA antibody fragment. IHC of tumors
showed strong staining of NA3-CD5, whereas TR(1–99)-NA3 stained weakly. Specific targeting
of TR(1–99)-NA3 or NA3-CD5 was shown by PET in xenografted mice.
Conclusions: The in vivo imaging studies suggest a potential application of the internalizing form
of CEA (N-A3) as a PET reporter gene.
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Introduction
The use of reporter genes enables researchers to inves-tigate and monitor the expression of genes of interest
both in cell culture and in vivo. Currently, in vivo imaging of
gene transfer using reporter genes has become increasingly
important in gene therapy trials due to the ability to
noninvasively determine the level of gene transfer over
time. In support of this, several groups have utilized optical,
magnetic, or nuclear imaging techniques to evaluate gene
transfer in animal models. In optical imaging studies, genes
inducing fluorescence or bioluminescence have been used
very successfully in mouse models [1, 2]. However, these
approaches are limited for human studies due to low tissue
penetration and high scattering of the fluorescent or bio-
luminescent signal, and potential immunogenicity of the
fluorescent or luminescent proteins. In contrast, positron
emission tomography (PET) imaging of reporter gene
expression is especially promising due to the inherent
sensitivity, high resolution, and quantitation provided by
PET, as well as the potential for clinical translation. In
general, PET imaging techniques have used either enzymes
or receptors as reporter genes. Established PET reporter
systems include the herpes simplex virus 1 (HSV-1)
thymidine kinase (tk; wild-type or sr39 mutant versions),
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using [18F] or [124I]-labeled nucleoside analogs, such as
FPCV, FHBG, FHPG, and FIAU as reporter probes [3, 4].
Alternatively, the human dopamine type 2 receptor (D2R)
and the somatostatin receptor (SSTr) in conjunction with
their respective reporter probes, [18F] FESP and [111In]-
DTPA-D-Phe1-octreotide, have been extensively explored
[5, 6]. Additional reporter systems include the sodium iodide
symporter (NIS) [7] and the human norepinephrine trans-
porter (hNET), which has been recently used to image
adoptively transferred human antigen-specific T cells in
mice [8]. Each system has its advantages and limitations
pertaining to immunogenicity and potential use as a suicide
gene (tk), target specificity, uptake levels, background in
normal tissues (NIS), and potential for unwanted biological
activity (D2R, SSTr, NIS, hNET) discussed in reference [9].
To reduce the likelihood of immunogenicity and/or
ectopic expression, which is a concern for reporter gene
expression, we designed a recombinant reporter gene based
on the human carcinoembryonic antigen (CEA). CEA is an
oncofetal antigen with a low level of expression in the lumen
of the colon in normal human adults and no confirmed
function [10]. CEA expression increases during the develop-
ment of cancer, with 95% of human colon cancers being
CEA positive, as well as a variable proportion of other
carcinomas such as breast, lung, ovarian, and others [11]. In
this work, the CEA-based reporter gene is detected by
molecular imaging using a well-established radiolabeled
anti-CEA antibody fragment as a reporter probe [12]. We
have previously generated several engineered antibody
fragments derived from the murine anti-CEA T84.66
monoclonal antibody (mAb) [13]. These recombinant anti-
body fragments have achieved high levels of uptake in
tumor xenografts (10–25% ID/g) resulting in high contrast
images following radiolabeling with the positron-emitting
radionuclides 64Cu or 124I [14–16]. Expression of the full-
length, native human CEA in tumor cells has previously been
used for the purpose of enhancing localization of radio-
iodinated intact mouse anti-CEA mAb [17]. In this study,
significant amounts of radioactivity remained in the circulation
5 days post tracer injection, resulting in a low tumor-to-blood
ratio (0.9±0.6). This low ratio is probably attributed to the
extended serum half-life of the intact mAb. We have recently
reported on a noninternalizing CEA reporter gene that was
evaluated by PET imaging [9]. This reporter gene was
composed of the two CEA domains (N and A3) fused to a
truncated version of the noninternalizing human FcγRIIb cell
surface receptor for stable membrane anchorage. Xenografts
from NA3-FcγRIIb transfected Jurkat T lymphocytes were
visualized by PET imaging, using 124I-labeled anti-CEA
single-chain (sc) Fv-Fc antibody fragment. In this study, a
tumor-to-soft tissue ratio of 6.1 to 1 at 20 h was achieved.
Here we have investigated two internalizing versions of
CEA (N-A3) as potential human reporter genes. The A3
domain contains the epitope recognized by the cT84.66 mAb
[18]. The N-A3 minigene was fused to the human transferrin
(CD71) receptor (TR(1–99)-NA3) and to the CD5 receptor
(NA3-CD5) replacing their extracellular domains (ECDs)
while retaining the intracellular and transmembrane domains.
Both constructs were transfected into Jurkat T cells, and the
CEA reporter gene expression and ability to internalize were
evaluated. We demonstrated that the expression of both
versions of the internalizing CEA reporter genewas maintained
in vivo, in tumor-bearing mice. An in vivo micro-PET
imaging study using an 124I-labeled anti-CEA scFv-Fc
antibody fragment as a probe showed specific localization
to transfected Jurkat T cell xenografts. Thus, we have
demonstrated the ability to generate and express an internal-
izing reporter gene on the surface of T cells, both in vitro
and in vivo supporting the potential use of the internalizing
forms of CEA as PET reporter genes.
Materials and Methods
Generation of Recombinant CEA Reporter Gene
The generation and expression of N-A3 as a fusion protein in a
mammalian system has previously been described [9]. Here, the N-
A3 minigene was fused to the human transferrin receptor (TfR)
(CD71) to produce a chimera between the N-terminal cytoplasmic
and transmembrane sequences (1–99 amino acids) and the N-A3
gene of CEA (Fig. 1a). The TfR, lacking its ECD, was isolated
from the pOTB7 vector (American Type Culture Collection
[ATCC] MGC-3151, Manassas, VA) by polymerase chain reaction
(PCR), using CD71 gene-specific primers. The PCR product was
inserted into the pUC19 vector (New England Biolabs, Inc.,
Ipswich, MA) already containing the N-A3 minigene. The resulting
full-length TR(1–99)-NA3 cDNA was then cloned into the
mammalian expression vector pcDNA3.1™/neo(−) (Invitrogen,
Carlsbad, CA) on XbaI and EcoRI sites (Fig. 1a).
The human CD5 receptor gene, lacking its ECD, was isolated from
the pCMV-SPORT6 vector (ATCCMGC-34370) by PCR, using CD5
gene-specific primers. Site-specific mutations (T410A and T412A)
were introduced in the cytoplasmic domain of CD5 using a Quick-
Change Site Directed Mutagenesis kit (Stratagene, La Jolla, CA)
according to manufacturer's directions (Fig. 1b). The plus strand
mutagenesis primers were T410A: 5′-CCATCGCAACCACGCGG
CAACCGTCCG-3 ′ and T412A: 5 ′-CGCAACCACGCGG
CAGCCGTCCGATCCCATGC-3′. In order to generate the T410A/
T412A double mutant, CD5 with the introduced T410A mutation
served as a DNA template for the second mutagenesis reaction with
the T412A primer. The CD5 T410A/T412A was inserted into the
pcDNA 3.1™/Zeo(−) vector (Invitrogen), already containing the N-
A3 minigene on XhoI and EcoRI sites (Fig. 1b) [9].
Cell Culture and Establishment of Stably
Transfected Clones
Human Jurkat cells (T cell leukemia, ATCC TIB-152) were
maintained as recommended. For stable transfection, 1×106 Jurkat
cells were electroporated as described [19] with 10 μg of linearized
DNA (digested with PvuI restriction enzyme). Clones expressing
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TR(1–99)-NA3 were selected at 400 μg/mL of G418 (Calbiochem,
San Diego, CA), while clones expressing NA3-CD5 were selected
at 200 μg/mL of Zeocin (InvivoGen, San Diego, CA). Stably
transfected cell lines were expanded and maintained in the
respective drugs used for selection.
Evaluation of Reporter Gene Expression
by Flow Cytometry
Jurkat cells (transfected and nontransfected) resuspended in 1×
phosphate-buffered saline (PBS) containing 1% fetal bovine serum
(FBS) were incubated with 2 μg of anti-CEA scFv-Fc H310A
antibody fragment [12] for 1 h at 4°C. Reporter protein expression
was detected with R-phycoerythrin (PE)-conjugated goat anti-
human (Fcγ-specific) mAb (Jackson Immunoresearch Laboratories,
West Grove, PA). Antibody binding to the cells was analyzed by a
FACSCalibur flow cytometer (Becton Dickinson, UK), detecting
PE (FL2, λem: 575±13 nm) fluorescence (mean fluorescence
intensity [MFI]). All data were analyzed using the Cell Quest
software (Becton Dickinson).
Confirmation of Reporter Gene Internalization
by Confocal Microscopy
TR(1–99)-NA3 transfected and nontransfected Jurkat cells were
plated on poly-L-lysine-coated glass coverslips (BD Biosciences,
San Jose, CA) in 12-well plates, containing Cellgro RPMI 1640
Medium 1× (Mediatech Inc., Manassas, VA) supplemented with
5% FBS. One day after plating, cells were incubated with 2 μg of
cT84.66 anti-CEA antibody for 30 min at 4°C and then shifted to
37°C. Internalization was assayed at 0 and 24 h. At the designated
time points (0 or 24 h), cells were washed with PBS and fixed in
4% paraformaldehyde for 10 min at room temperature. To
determine the expression of total recombinant reporter protein,
a
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Fig. 1. Schematic gene and protein representations of the two internalizing recombinant CEA reporter molecules. TMD =
transmembrane domain, CTD = cytoplasmic domain. The restriction enzyme cut sites are included. a TR(1–99)-NA3 reporter
gene construct. The tetrapeptide sequence YTRF in the CTD of the TfR is responsible for internalization. b NA3-CD5 reporter
gene construct. The two residues (T410 and T412) in the CTD of CD5 were mutated to alanine residues in order to eliminate
normal biological activity.
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following fixation cells were permeabilized with 0.2% Triton X-
100 and blocked for 20 min with PBS containing 1% FBS. Finally,
cells were stained with Alexa Fluor 488-conjugated goat anti-
human IgG (H + L) antibody (Sigma-Aldrich) in PBS containing
1% FBS and 0.1% Triton X-100. The coverslips were mounted on
glass slides and visualized under Leica TCS-SP inverted confocal
microscope (Leica TCS-SP, Heidelberg, Germany) using a ×100 oil
immersion objective lens.
Antibody Internalization Assay
The anti-CEA cT84.66 antibody was labeled with 125I, using
carrier-free [125I]-NaI (MP Biomedicals, Inc., Irvine, CA) and
Iodogen-coated tubes (Pierce, Rockford, IL), according to manu-
facturer's instructions. Unbound radioiodine was separated from the
radiolabeled antibody using a PD-10 desalting column (GE
Healthcare, Piscataway, NJ). NA3-CD5 transfected Jurkat cells
were seeded in a 12-well plate at a density of 106 cells/mL.
Twenty-four hours later, cells were incubated in triplicate with
105 cpm of 125I-labeled cT84.66 antibody fragment in serum-free
RPMI media on ice for 30 min. The cells were then transferred to
microfuge tubes, spun down, and washed three times with ice-cold
RPMI media, followed by incubation at 37°C for 0, 2, 10, 30, and
60 min in RPMI media. After the indicated times, the medium was
removed and cells were washed twice with 500 μL of ice-cold
glycine buffer (500 mM NaCl, 0.1 M glycine, pH 2.5) for 3 min in
order to remove surface-bound radioiodinated antibody. The radio-
activity that remained cell associated (intracellular) and in the
glycine wash (surface-bound) was counted in a gamma counter
(Wallac Wizard 3″ 1480; Perkin Elmer Life and Analytical
Sciences, Shelton, CT). The proportion of the internalized antibody
was determined as the ratio of cell-associated radioactivity
(internalized antibody) to the sum of cell-associated (internalized
antibody) and acid-rinsed (surface-bound antibody) radioactivity.
Establishment of Tumor Xenografts
All animal studies were conducted under protocols approved by the
Chancellor's Animal Research Committee at University of California,
Los Angeles (UCLA). Reporter gene transfected and nontransfected
Jurkat xenografts were established as described [9]. Briefly, for each
study, three or four 7- to 8-week-old female athymic nude mice
(Charles River Laboratories, Wilmington, MA) were sublethally
irradiated with 450 rad in a 137Cs source irradiator (Mark-1, Model
68A; JL Shepherd and Associates, San Fernando, CA). Three days
later, the irradiated mice were injected subcutaneously (s.c.) in the left
shoulder region with a 1/1 mixture of 1×106 N-A3 transfected Jurkat
and 1×106 irradiated (6500 rad) HT-1080 feeder cells (human
fibrosarcoma, ATCC CCL-121). The right shoulder area was injected
with the nontransfected Jurkat/feeder cell suspension as a negative
control. Tumor masses were allowed to develop for about 20 days.
Immunohistochemistry
Immunohistochemical (IHC) staining was performed on both
paraffin-embedded and frozen sections of transfected and non-
transfected Jurkat cell tumors as described [9, 20]. TR(1–99)-NA3
transfected Jurkat tumor sections were stained with the intact
cT84.66 mAb, while the NA3-CD5 transfected Jurkat tumor
sections were stained with the anti-CEA scFv-Fc H310A antibody
fragment. Staining was developed using biotinylated goat anti-
human (H + L) antibody (1:400) and horseradish peroxidase-
conjugated avidin provided by the Vectastain Elite ABC kit (Vector
Labs, Burlingame, CA). Stained tumor sections were examined at a
magnification of ×20 and photographed.
124I Labeling of scFv-Fc Antibody Fragments
Radioiodination of the anti-CEA scFv-Fc fragments with 124I was
performed by the Iodogen method as described [12]. Briefly,
0.2 mg of antibody was incubated with 0.4–0.8 mCi Na124I (IBA
Molecular, Sterling, VA) using polypropylene tubes coated with
20 μg Iodogen (Pierce). The labeling efficiencies were 81.5% for
scFv-Fc H310A/H435Q and 89.9% for scFv-Fc H310A, as
measured by instant TLC (Tec-Control kit; Biodex Medical
Systems, Shirley, NY). Immunoreactivity was 63% for scFv-Fc
H310A/H435Q as determined by incubation of the labeled protein
with excess LS174T cells (ATCC CL-188) overexpressing CEA.
DOTA-Conjugation and 64Cu-Labeling of scFv-Fc
H310A Antibody Fragment
Purified anti-CEA scFv-Fc H310A fragment (1 mg) was conjugated
to 1,4,7,10-tetraazacyclododecane-N,N′,N′′,N′′′-tetraacetic acid
(DOTA; Macrocyclics, Dallas, TX), using the water-soluble N-
hydroxysuccinimide method, as described [21, 22]. Following
conjugation, the protein was extensively dialyzed in 0.9% NaCl
(pH 7.2) and concentrated.
The positron-emitting isotope 64Cu (copper chloride in 0.1 mol/L
HCl; radionuclide purity, 999%) was provided by Mallinckrodt
Institute of Radiology (Washington University School of Medicine,
St. Louis, WA). The DOTA-conjugated scFv-Fc H310A fragment
(0.3 mg) was incubated with 0.440 mCi of 64Cu, as described [23].
The labeling efficiency was 56.2% as determined by instant TLC
(Tec-Control kit, Biodex Medical Systems).
Micro-PET Imaging and Statistical Analysis
Mice were imaged using the micro-PET Focus 220 instrument
(Siemens Preclinical Solutions, Inc., Knoxville, TN). Prior to 124I
imaging, thyroid and stomach uptake of radioiodine was blocked as
described [15]. Three mice carrying Jurkat TR(1–99)-NA3 xenografts
were injected in the tail vein with 139–143 μCi 124I-labeled scFv-Fc
H310A/H435Q and serially imaged after 24 and 48 h of uptake time.
Four mice carrying NA3-CD5 transfected Jurkat tumors were injected
with 105–113 μCi 124I-labeled scFv-Fc H310A, and another four mice
were injected with 99–102 μCi 64Cu-labeled scFv-Fc H310A and
serially imaged at 4 and 19–21 h post injection. Acquisition time was
10 min (one bed position), while mice were anesthetized with 2%
isoflurane. Immediately after the last scan, anesthetized mice were
euthanized by administration of 100 μl of pentobarbital (50 mg/mL)
intraperitoneally. Mice were dissected and blood, tumors, liver,
spleen, kidneys, and lungs were harvested, weighted, and counted
in a well counter (Cobra II Auto-Gamma; Packard, Illinois), and
the %ID/g was calculated. The images were reconstructed using a
filtered backprojection algorithm (FBP) [24]. All images were
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displayed by the AMIDE software [25], and regions of interest (ROI)
were drawn as described [15]. The variance amongmice is represented
as mean (±SD). The uptakes in blood, tumors, and organs (%ID/g)
were compared for significant difference using an unpaired Student t
test. A 1-tailed P value of less than or equal to 0.05 was considered
statistically significant.
Results
Assembly and Expression of Internalizing
Recombinant CEA Reporter Genes
In order to create CEA as a recombinant reporter capable of
internalization, the truncated form of CEA, N-A3, composed
of 726 nucleotides [18], was genetically linked to one of two
internalizing receptors, transferrin and CD5. The human TfR
is a type II transmembrane protein (i.e., N-terminus inside,
C-terminus outside) that is rapidly internalized upon binding
with transferrin. The uptake and recycling of the TfR have
been determined to be dependent on the amino acid motif
Tyr–Thr–Arg–Phe (YTRF), which is located in the cyto-
plasmic domain (position 20–23 amino acid) [26]. In the
present study, N-A3 was fused to the C-terminus (1–99
amino acids) of the intracellular and transmembrane regions
of the TfR, replacing the extracellular transferrin-binding
domain (Fig 1a). The construct was termed TR(1–99)-NA3.
The N-A3 minigene was also fused to CD5, which is a
type I integral membrane protein and a key regulator of
antigen receptor-mediated differentiation of T and B cells
[27]. CD5 is composed of three extracellular cysteine-rich
domains, a transmembrane region, and a cytoplasmic
“immunoreceptor tyrosine-based activation motif” (ITAM)
domain. Tyrosine 429, located in the cytoplasmic domain of
CD5, is responsible for internalization [27]. The N-A3
minigene was fused to the N-terminal side of the CD5
transmembrane and intracellular regions, replacing the
extracellular cysteine-rich domains. The construct was
termed NA3-CD5 (Fig 1b). Two conserved threonine
residues (T410 and T412), located in the membrane
proximal cytoplasmic region of CD5 and responsible for
cellular signaling, were mutated to alanines for elimination
of their biological activity [28].
In order to evaluate the expression of recombinant CEA
reporters on Jurkat cells, TR(1–99)-NA3 and NA3-CD5
transfected Jurkat cells were incubated with the anti-CEA
antibody and examined by flow cytometry. Nontransfected
Jurkat cells were used as a negative control. Although the
fluorescence intensity shifted both cell types to the right
(Fig. 2), the MFI values differed almost four fold. The MFI
value for TR(1–99)-NA3 transfected cells was 26 versus 92
for NA3-CD5 transfected cells. When cells were passaged
and examined for expression over time, we noted that the
cell surface expression of NA3-CD5 remained relatively
stable, whereas TR(1–99)-NA3 expression of recombinant
protein consistently dropped over time. Western blot
analyses of the recombinant proteins (TR(1–99)-NA3 and
NA3-CD5) showed that they migrated consistent with their
predicted molecular weights (approximately 42 kDa for
both) under reducing conditions (data not shown).
Internalization of Anti-CEA Antibody Fragments
Internalization of the recombinant TR(1–99)-NA3 reporter
protein, containing the TfR internalization sequence YTRF,
was monitored by confocal laser scanning microscopy.
Immunofluorescence, utilizing anti-CEA antibodies, showed
surface staining of TR(1–99)-NA3 transfected Jurkat cells at
0 h and cytoplasmic staining at 24 h (Fig. 3a), which
demonstrates internalization of the recombinant reporter
protein. Control, nontransfected Jurkat cells showed no
membrane staining at 24 h (Fig 3a).
The internalization of NA3-CD5 transfected Jurkat cells
was investigated in the presence of 125I-labeled anti-CEA
scFv-Fc H310A antibody fragment. The kinetics of NA3-
CD5 internalization showed that endocytosis was very rapid
(Fig. 3b). Within 5 min, more than 90% of the radiolabeled
antibody fragment was internalized. The rapid internal-
ization via NA3-CD5 was also observed by flow cytometry
internalization studies (data not shown).
Expression of Recombinant CEA Reporter
Proteins in Transfected Jurkat Tumors
Subcutaneous tumors were established in athymic nude mice
by coinjecting transfected or nontransfected Jurkat cells with
irradiated HT1080 human sarcoma feeder cells, respectively.
Tumors were excised, frozen, and analyzed for expression of
CEA by IHC. Immunohistochemical staining of tumors
produced by TR(1–99)-NA3 transfected Jurkat cells showed
that the expression of protein was very low (Fig. 4a),
whereas the expression of NA3-CD5 transfected Jurkat
tumors was more prominent (Fig. 4b).
Micro-PET Imaging of Jurkat Xenografts
Expressing TR(1–99)-NA3
Micro-PET imaging was employed to evaluate the in vivo
targeting of anti-CEA antibody fragments to the CEA
reporter protein-positive tumors. For this purpose, nude
TR(1-99)-NA3 NA3-CD5
Fig. 2. Flow cytometry analysis of recombinant CEA
reporter protein expression in Jurkat T cells. Nontransfected
Jurkat (solid gray) and transfected Jurkat (black line).
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mice (n=3) carrying TR(1–99)-NA3 (CEA-positive) and
parental Jurkat (CEA-negative) tumors were injected with
the 124I-labeled anti-CEA scFv-Fc H310A/H435Q antibody
fragment. Whole-body micro-PET scans were obtained at 24
and 48 h post tracer injection. Uptake in the CEA-positive
tumor and low activity in the CEA-negative control tumor
were seen at 24 h (Fig. 5a). At 48 h, no signal was detected
in the positive tumor. The average tumor-to-background ratio
at 24 h, based on ROI analyses, was 2.8. A biodistribution
after the last scan (48 h) revealed that the TR(1–99)-NA3
expressing tumor had 0.95±0.007% ID/g, which was
significantly different (P=.030) from the uptake in the
negative tumor (0.59±0.06% ID/g), resulting in a positive to
negative tumor ratio of 1.6. The radioactive uptake in the
positive tumor was also significantly different from the
activities in liver and kidneys (PG .05), but not significantly
different from the activities in spleen and lungs (P9 .05).
Micro-PET Imaging of Jurkat Xenografts
Expressing NA3-CD5
Four mice bearing NA3-CD5 transfected Jurkat tumors were
evaluated by micro-PET imaging using 124I-labeled scFv-Fc
H310A fragment [12]. Although no signal was detected in
the NA3-CD5-positive tumor in any of the images, biodis-
tribution at 21 h showed uptake of 0.65±0.04% ID/g in the
CEA-positive tumor and 0.30±0.14% ID/g in the control
tumor, which was significantly different (P=.023). Thus, the
positive to negative tumor ratio was 2.2. The uptake in
the positive tumor was not significantly different from the
uptake in the kidneys (P=.076) but was significantly higher
than the uptakes in liver and spleen (PG .05). Furthermore,
there was significantly more radioactivity (PG .05) in the
blood (2.1±0.31% ID/g) and lungs (1.2±0.38% ID/g). Since
the low uptake in NA3-CD5 xenografts may be due to rapid
internalization upon tracer binding, another attempt to image
NA3-CD5-positive tumors, using 64Cu-labeled anti-CEA
scFv-Fc H310A fragment, was made with another group of
four mice. In this study, the signal from the liver was very
high (22.5±4.48% ID/g; P=.007), obscuring any signal
coming from the tumor. In addition, radioactivities in spleen,
kidneys, and lungs were also significantly higher (PG .05)
than the activity in the positive tumor at the time of
euthanasia (21 h). Importantly, the radioactive uptake in
the positive tumor (2.78±0.84% ID/g) was significantly
more (P=.040) than the uptake in the nontransfected,
parental Jurkat tumor (1.22±0.17% ID/g), resulting in a
positive to negative tumor ratio of 2.3 (Fig. 5b).
Discussion
The present study describes the construction and expression
of two recombinant CEA reporter genes for the ultimate
purpose of tracking genetically modified T cells in vivo. We
have recently reported on a noninternalizing recombinant
NA3-FcγRIIb fusion reporter gene that was expressed in
Jurkat cells [9]. Here, we proceeded to make internalizing
reporter genes for the purpose of trapping and increasing the
accumulation of radioactive tracer uptake in cells expressing
these reporter genes. This would presumably translate into
stronger signal in imaging applications. Two internalizing
recombinant CEA reporter genes, TR(1–99)-NA3 and NA3-
CD5, were generated and stably transfected in human helper
T Jurkat cells. The expression of the reporter proteins
differed significantly when cells were evaluated by flow
cytometry and when cells were grown as tumors and stained
0 h 24 h
TR(1-99)-NA3 
transfected 
Jurkat
Non-transfected 
Jurkat
DIC image of Non-
transfected Jurkat
a
b
Fig. 3. Antibody-dependent internalization of recombinant
CEA reporter protein. a Confocal microscopy image of TR(1–
99)-NA3 transfected Jurkat cells labeled with anti-CEA
cT84.66 mAb at 0 and 24 h. Nontransfected Jurkat cells
were used as a negative control, shown at 24 h. A differential
interference contrast (DIC) image of nontransfected Jurkat
cells stained with cT84.66 at 24 h is shown. b Kinetics of
NA3-CD5 internalization, determining uptake of anti-CEA
cT84.66 in transfected Jurkat cells over time. Samples were
assayed in triplicates and data are presented as mean ±
SEM.
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by IHC. The TR(1–99)-NA3 transfected Jurkat cells showed
low levels of reporter protein expression, relatively to that of
NA3-CD5. Nevertheless, specific targeting to TR(1–99)-
NA3 transfected Jurkat xenografts was demonstrated with
the rapid clearing radioiodinated anti-CEA scFv-Fc H310A/
H435Q fragment (t1/2β=6–8 h) [12, 29] by in vivo micro-
PET imaging. Reporter-positive tumors showed clear signal
at 24 h (Fig. 5), and the tumor-to-background ratio,
determined by ROI analysis of the images, was 2.8. In our
previous study with the noninternalizing NA3-FcγRIIb
reporter gene, we determined tumor-to-background ratio of
6.1 at 20 h in tumors, showing stronger IHC staining and
expressing about 25,000 reporters per cell [9]. This
observation suggests that even tumor masses with lower
than 25,000 surface reporters (i.e., TR(1–99)-NA3 trans-
fected Jurkat tumors) can still be detected by PET. Although
higher surface expression was achieved with the NA3-CD5
reporter gene (result from flow cytometry analysis and IHC
staining), micro-PET imaging using the slightly slower
clearing scFv-Fc H310A antibody fragment (t1/2β=21–
27 h) [12, 29] did not improve the tumor uptake at 21 h
with the positive to negative tumor ratio being 2.2. CD5
internalization efficiency has been found to be different with
different antibody fragments [27]. Our in vitro internal-
ization study, demonstrated rapid internalization of NA3-
CD5 recombinant reporters upon antibody binding. This
could possibly explain the low uptake of radioiodinated anti-
CEA scFv-Fc fragment by NA3-CD5 expressing xenografts
in the micro-PET imaging studies. Although radioiodination
is simple and can be useful in preliminary imaging studies,
internalized radioiodinated proteins are readily metabolized
to iodotyrosines that are rapidly washed out of tissues and
excreted into the urine in vivo [30]. Thus, direct radio-
iodination methods are generally not suitable for internaliz-
ing proteins as the signal is rapidly lost from the tissues. In
contrast, indirect radiolabeling approaches, resulting in
stable modification of the protein, are advantageous for
internalizing proteins as the label is retained and accumu-
lates in the cell over time. However, the disadvantage is that
activity is also retained in tissues involved in the clearance
of the protein (i.e., liver and kidneys), limiting imaging of
tumors proximal to these organs. When NA3-CD5 trans-
fected Jurkat xenografts were imaged with 64Cu-DOTA-
scFv-Fc H310A, a higher radioactive uptake in the positive
tumor was measured compared to the one achieved with the
radioiodinated fragment. However, use of 64Cu also resulted
in high normal tissue activities, especially in the liver, which
prevented visualization of the signal in the positive tumors.
Although the present study shows that the surface expression
level of NA3-CD5 is higher than that of TR(1–99)-NA3, the
imaging study suggests that it is not high enough to enable
sufficient accumulation in the tumors for production of high
Nontransfected Jurkat Transfected Jurkat
a
b
Fig. 4. Immunohistochemical staining of N-A3/CEA expression in tumors (×20 magnification). a Paraffin-embedded sections
of nontransfected and TR(1–99)-NA3 transfected Jurkat tumors stained with cT84.66 anti-CEA antibody. b Frozen sections of
nontransfected and NA3-CD5 transfected Jurkat tumors stained with anti-CEA scFv-Fc H310A antibody fragment.
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contrast images. The signal in the liver can be eliminated by
using a smaller antibody fragment that clears through the
kidneys such as the diabody (55 kDa, scFv dimer) as a
PET tracer. This fragment has demonstrated targeting to
antigen-positive tumors, while clearing rapidly from the
circulation, attaining favorable tumor-to-blood ratios at
early times [15].
In our previous study with the noninternalizing reporter
gene, cell populations with different expression levels (high,
medium and low) were generated [9]. In this study, trans-
fections of the Jurkat cells with the N-A3 reporter genes
were inefficient. Only one NA3-CD5 expressing clone was
found. This clone was a high expressor (MFI 995) that
maintained its high expression over time. Transfection of TR
(1–99)-NA3 reporter gene yielded several clones. However,
despite multiple attempts, only a few clones with limited
surface expression of TR(1–99)-NA3 reporter protein were
obtained. Jurkat cells are inherently difficult to transfect. A
study showed that electroporation of Jurkat cells resulted in
15.83±3.5% transfection efficiency [31]. For this reason,
several protocols (different voltage and number of pulses)
were developed to increase transfection efficiency. Since the
transfection efficiency was not a problem with the non-
internalizing NA3-FcγRIIb [9], other transfection
approaches than electroporation were not attempted. Another
observation similar to our study showed that chimeric feline
TfR formed by feline TfR cytoplasmic tail, transmembrane,
and stalk sequences with antibody single-chain variable
fragments (scFv) derived from antiviral (canine parvovirus
[CPV]) mAb was difficult to generate stably Jurkat cell lines
expressing levels of chimeric receptors high enough for
detection [32]. This experiment also supports the low
transfection efficiency and low-level expression of chimeric
receptors on Jurkat cells.
A potential problem that could affect expression of the TR
(1–99)-NA3 reporter gene may be the reverse orientation of the
N-A3 minigene (Fig. 1a), leading to incorrect folding and/or
perturbed tertiary structure. The human TfR has been
previously fused to the human IgG1 Fc region and expressed
on the surface of baby hamster kidney (BHK) cells [33]. In this
work, the Fc region was also inserted in the reverse orientation,
and high surface expression of the chimera from pCDNA 3.1
(−) vector following transfection was documented. Since CEA
is a member of the immunoglobulin supergene family, it is
unlikely that the reverse orientation of N-A3 affects its three-
dimensional structure. Another potential issue with expressing
recombinant proteins in Jurkat cells may be the promoter used.
The strength of various viral promoters (CMV, RSV, and
SV40) was examined in Jurkat cells [34]. It was found that the
CMV promoter was 10-fold stronger than the RSV promoter
and significantly stronger than the SV40 promoter in Jurkat
cells. In this work, the pCDNA 3.1(-) vector that contains the
CMV promoter for gene expression was used. Since the
orientation of the gene and the promoter used do not seem to be
an issue for expression in the work, the problem is probably the
Jurkat cell line.
In conclusion, the construction and characterization of
two recombinant internalizing CEA reporter genes with
apparently different internalization rates were completed.
The ability to noninvasively image reporter genes with PET
was shown using mice bearing TR(1–99)-NA3 reporter gene
transfected Jurkat xenografts. The strategy of using N-A3 as
reporter gene is not limited to T cells only. These studies
also suggest potential application of the recombinant CEA
(N-A3 minigene) as a reporter for noninvasive imaging of
any cell type (e.g., B cells, stem cells, or as a transgene in
animals). Future studies could optimize this system through
improvement of the recombinant reporter gene design (N-A3
orientation and internalization module) or through the use of
PET reporter probe of a smaller size. Of the two versions of
internalizing recombinant CEA reporter proteins made,
NA3-CD5 was the faster internalizing molecule than TR
(1–99)-NA3. Although we were not able to detect a signal
from the NA3-CD5 reporter positive tumor by micro-PET
imaging with the 64Cu-labeled anti-CEA scFv-Fc antibody
fragment, the biodistribution results indicated specific
targeting and accumulation of activity. Shifting to a smaller
antibody fragment, like the anti-CEA diabody or minibody
for the PET reporter probe, could improve image contrast
(+) (-)
a
(+) (-)
b
(+)
(-)
Fig. 5. Micro-PET imaging of CEA reporter proteins. aCoronal
and transverse views of a nude mouse with TR(1–99)-NA3
transfected (+) and nontransfected (−) xenografts, injected with
140 μCi of 124I-labeled anti-CEA scFv-Fc H310/H435Q frag-
ment at 24 h after injection. b Transverse view of a nudemouse
with NA3-CD5 transfected (+) and nontransfected (-) xeno-
grafts, injected with 100 μCi of 64Cu-labeled anti-CEA scFv-Fc
H310A fragment at 21 h postinjection.
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and target detectability. Finally, the immunogenicity that
both reporter genes may exhibit in humans needs to be
formally evaluated.
Conclusions
In this study, two internalizing CEA reporter genes, TR
(1–99)-NA3 and NA3-CD5, were expressed on the
surface of Jurkat T cells. Expression was confirmed by
flow cytometry and IHC. In serial small animal PET
imaging studies, only the TR(1–99)-NA3 expressing
Jurkat tumor xenografts could be visualized by using an
124I-labeled tracer. By using a 64Cu-labeled tracer, the
NA3-CD5 reporter expressing Jurkat xenografts could be
imaged. However, signal accumulation was low due to
rapid internalization and low expression levels of the
reporter genes on the cell surface. Optimization of the
reporter gene design and boost in the expression level is
required for improvement of the signal accumulation in
the reporter gene expressing tumors.
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